Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study
- PMID: 38339935
- PMCID: PMC11191486
- DOI: 10.3233/JAD-231295
Early Detection Screening of Cognitive Decline in Patients Over 60 Years: ELDERCARE Study
Abstract
Background: Dementia is the fourth leading cause of death in people > 65 years old in western countries.
Objective: This cross-sectional assisted survey aimed to evaluate a multidisciplinary team approach of specialists of the Associazione Geriatri Extraospedalieri a favore di Anziani Svantaggiati and pharmacists to facilitate progress in the early identification and management of cognitive decline in patients > 60 years.
Methods: A multidisciplinary team conducted this cross-sectional assisted survey. Patients (>60 years) with independent and/or assisted walking, subjective memory impairment, mild cognitive impairment or mild Alzheimer's disease (AD) who regularly attended pharmacies underwent the survey. An internal medical examination, a cardiovascular visit, and a short neuropsychological evaluation were conducted for each patient. Demographic, anamnestic, and clinical data were collected anonymously.
Results: 279 eligible patients underwent the screening phase. 44% were overweight, 23% obese and 29% hypertensive. 62% of cases showed alterations of supra-aortic trunk with different percentages of stenosis. The neuropsychological evaluation highlighted that 67% of cases were normal according to age and education level, while 18% were in a state condition of cognitive frailty. Mild/moderate cognitive decline, or probably AD, was identified in 14% of cases.
Conclusions: A multidisciplinary collaboration between pharmacists and specialist medical doctors is essential in early identification of prodromal symptoms of cognitive impairment and AD. The Prompt detection of the condition in this group of patients allowed the specialists to recommend in-depth diagnostic tests and follow-up procedures to slow the course of the disease. This would give time to carry out adequate caregiver training.
Keywords: Alzheimer’s disease; cognitive dysfunction; elderly; frail elderly; observational study.
Conflict of interest statement
The author reports no conflicts of interest in this work.
Figures
Similar articles
-
Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.Neurol Sci. 2018 Mar;39(3):557-564. doi: 10.1007/s10072-018-3261-1. Epub 2018 Jan 30. Neurol Sci. 2018. PMID: 29383614
-
Alexithymia in people with subjective cognitive decline, mild cognitive impairment, and mild Alzheimer's disease.Aging Clin Exp Res. 2017 Dec;29(6):1105-1111. doi: 10.1007/s40520-017-0725-8. Epub 2017 Jan 21. Aging Clin Exp Res. 2017. PMID: 28110464
-
Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.Curr Aging Sci. 2019;11(4):242-249. doi: 10.2174/1874609812666190204094233. Curr Aging Sci. 2019. PMID: 30845903 Free PMC article.
-
Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.Curr Alzheimer Res. 2022;19(3):202-211. doi: 10.2174/1567205019666220404104854. Curr Alzheimer Res. 2022. PMID: 35379127
-
[Awareness disorders in Alzheimer's disease and in mild cognitive impairment].Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11. Encephale. 2014. PMID: 24630532 Review. French.
Cited by
-
Developing a Patient Profile for the Detection of Cognitive Decline in Subjective Memory Complaint Patients: A Scoping Review and Cross-Sectional Study in Community Pharmacy.Healthcare (Basel). 2025 Jul 14;13(14):1693. doi: 10.3390/healthcare13141693. Healthcare (Basel). 2025. PMID: 40724718 Free PMC article.
References
-
- WHO (2015) The epidemiology and impact of dementia: Current state and future trends. Geneva:World Health Organization; Document WHO/MSD/MER/15.3, available at http://www.who.int/mental_health/neurology/dementia/dementiathematicbrie.... Accessed March 8, 2017.
-
- Long S, Benoist C, Weidner W (2023) World Alzheimer Report 2023: Reducing dementia risk: Never too early, never too late. Alzheimer’s Disease International, London, England. https://www.alzint.org/u/World-Alzheimer-Report-2023.pdf. Accessed October 25, 2023.
-
- Alzheimer’s Disease International and WHO (2012) Dementia: A public health priority. Geneva: World Health Organization, http://www.who.int/mental_health/publications/dementia_report_2012/en/. Accessed March 8, 2017.
-
- Claudia P, Volpe U (2019) ‘Italy’, Dementia Care: International Perspectives. In Dementia Care: International Perspectives, Burns A, Robert P, eds. Oxford Academic, Oxford, UK. https://doi.org/10.1093/med/9780198796046.003.0025. Accessed February 10, 2023.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical